Identification of novel HIV-1-derived HLA-E-binding peptides
Non-classical class Ib MHC-E molecule is becoming an increasingly interesting component of the immune response. It is involved in both the adaptive and innate immune responses to several chronic infections including HIV-1 and, under very specific circumstances, likely mediated a unique vaccine prote...
Autors principals: | Hannoun, Z, Lin, Z, Brackenridge, S, Kuse, N, Akahoshi, T, Borthwick, N, McMichael, A, Murakoshi, H, Takiguchi, M, Hanke, T |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Elsevier
2018
|
Ítems similars
-
Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
per: Murakoshi, H, et al.
Publicat: (2018) -
Control of HIV-1 by CD8+T cells specific for epitopes of conserved mosaic vaccine immunogens
per: Murakoshi, H, et al.
Publicat: (2018) -
Effective suppression of HIV-1 replication by cytotoxic T lymphocytes specific for pol epitopes in conserved mosaic vaccine immunogens
per: Zou, C, et al.
Publicat: (2019) -
CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
per: Murakoshi, H, et al.
Publicat: (2018) -
HLA-E-presented peptides as novel targets for HIV-1 therapy
per: S. Brackenridge, et al.
Publicat: (2019-12-01)